At a glance
ClinicalIndex Comparison RecordN/ACompleted· 49 enrolled
Drug / intervention
Low energy shock wave +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Low Energy Shock Wave for the Treatment of Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) - a Randomized, Double-blind, Placebo-controlled, Prospective Study
In Brief
A clinical study evaluating Low energy shock wave and Placebo for Interstitial Cystitis. Completed, enrolled 49 participants across 1 site.
Detailed Summary
To investigate the efficacy and safety of LESW on participants with IC/BPS
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInterstitial Cystitis
CountriesTaiwan
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartJul 2018
First PostedAug 2018
Primary CompletionFeb 2020
Study CompletionJun 2020
TodayJul 2026
First PostedAug 8, 2018
Enrollment StartJul 4, 2018
Primary CompletionFeb 26, 2020
Study CompletionJun 30, 2020
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 7.9 years ago
Interventions
Low energy shock wavedevice
Probe be transcutaneous applied to the suprapubic bladder region with 2000 shocks, frequency of 3 pulses per second and maximum total energy flow density 0.25 millijoule/mm2 once a week for 4 weeks
Placebodevice
Probe be transcutaneous applied to the suprapubic bladder region with 2000 shocks, frequency of 3 pulses per second but no energy once a week for 4 weeks